Vincent Medical Holdings Limited (1612) Stock Statistics & Valuation Metrics

Vincent Medical Holdings Limited has a market cap or net worth of HK$560.49M. The enterprise value is HK$478.53M.

Vincent Medical Holdings Limited has 659,395,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vincent Medical Holdings Limited’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 12.72%.

The current PE Ratio of Vincent Medical Holdings Limited is 5.1. Vincent Medical Holdings Limited’s PEG ratio is 0.11.

In the last 12 months, Vincent Medical Holdings Limited had revenue of 932.78M and earned 104.38M in profits. Earnings per share was 0.16.

In the last 12 months, operating cash flow was 168.42M and capital expenditures -113.78M, giving a free cash flow of 54.64M billion.

Vincent Medical Holdings Limited pays an annual dividend of HK$0.024, resulting in a dividend yield of 4.94%

Vincent Medical Holdings Limited upcoming earnings date is Aug 26, 2026, TBA (Confirmed).

Vincent Medical Holdings Limited as a current ratio of 1.96, with Debt / Equity ratio of 26.69%

In the past 12 months, Vincent Medical Holdings Limited has paid 21.29M in taxes.

Vincent Medical Holdings Limited EV to EBITDA ratio is 2.76, with an EV/FCF ratio of 8.45.

Vincent Medical Holdings Limited has HK$250.87M in cash and marketable securities with HK$177.42M in debt, giving a net cash position of HK$73.46M billion.

Gross margin is 35.10%, with operating margin of 13.94%, and net profit margin of 11.19%.

The average price target for Vincent Medical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―